US Patent Issued to Lapix Therapeutics on Aug. 19 for "Compositions and methods for reducing immune intolerance and treating autoimmune disorders" (Massachusetts, Michigan Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,434, issued on Aug. 19, was assigned to Lapix Therapeutics Inc. (Cambridge, Mass.).

"Compositions and methods for reducing immune intolerance and treating autoimmune disorders" was invented by Anas M. Fathallah (Wakefield, Mass.), Scott D. Larsen (Gobles, Mich.) and Abdulraouf Ramadan (Malden, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds and their pharmaceutically acceptable salts, lipid particles comprising such compounds or pharmaceutically acceptable salts thereof and compositions of the foregoing that can be used to reduce immune intolerance in a subject, for example, to treat autoimmune disorders, or in com...